CompletedNCT05891548
Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration
PHASE2 · 60 planned enrolment
- Countries listed
- 1
- Registry update
- July 25, 2025
Registry Intervention View
CLS-AX
Trial registrations containing the exact intervention label CLS-AX.
Exact registry label · Not reported
3 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
2 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
CompletedNCT05131646
Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study
Phase not reported · 15 planned enrolment
- Countries listed
- 1
- Registry update
- March 4, 2024
CompletedNCT04626128
Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD
PHASE1 · PHASE2 · 27 planned enrolment
- Countries listed
- 1
- Registry update
- September 18, 2023